deltatrials
Completed PHASE1 INTERVENTIONAL 18-arm NCT01712906

A Phase I, Safety Study of Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17) in Chinese Children

A Phase II Clinical Trial for Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17) in Chinese Children

Sponsor: Hebei Provincial Center for Diseases Control and Prevention

Conditions Mumps
Interventions 0 logCCID50/ml 3.50±0.25logCCID50/ml 4.25±0.25 logCCID50/ml 5.00±0.25 logCCID50/ml Attenuated Mumps vaccine (Zhe Jiang Vacn Bio-pharmaceutical Co., LTD.; NO.20110528-1)
Updated 9 times since 2017 Last updated: Oct 7, 2023 Started: Oct 31, 2012 Primary completion: Apr 30, 2013 Completion: Apr 30, 2013
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01712906, this PHASE1 trial focuses on Mumps and remains completed. Sponsored by Hebei Provincial Center for Diseases Control and Prevention, it has been updated 9 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotCompleted~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Dec 2022 · 23 months · monthly snapshotCompleted~Dec 2022 – ~Oct 2023 · 10 months · monthly snapshotCompleted~Oct 2023 – ~Nov 2023 · 31 days · monthly snapshotCompleted~Nov 2023 – ~Jul 2024 · 8 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 24 months · monthly snapshotCompleted

Change History

9 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  3. Nov 2023 — Jul 2024 [monthly]

    Completed PHASE1

  4. Oct 2023 — Nov 2023 [monthly]

    Completed PHASE1

  5. Dec 2022 — Oct 2023 [monthly]

    Completed PHASE1

▶ Show 4 earlier versions

  1. Jan 2021 — Dec 2022 [monthly]

    Completed PHASE1

  2. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE1

  3. Feb 2017 — Jun 2018 [monthly]

    Completed PHASE1

  4. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE1

    First recorded

Oct 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Hebei Provincial Center for Diseases Control and Prevention
  • Institute of Medical Biology, Chinese Academy of Medical Sciences
Data source: Institute of Medical Biology, Chinese Academy of Medical Sciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations